IGC Pharma (IGC) Inventory Average (2011 - 2026)

IGC Pharma (IGC) has reported Inventory Average for 15 consecutive years, with $639000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Inventory Average fell 54.24% year-over-year to $639000.0 in Q1 2026; TTM through Mar 2026 was $639000.0, a 54.24% decrease from a year earlier, with the FY2026 full-year figure at $999000.0, down 31.1% from the prior year.
• Inventory Average was $639000.0 for Q1 2026 at IGC Pharma, down from $649000.0 in the prior quarter.
• Over five years, Inventory Average peaked at $4.5 million in Q1 2022 and troughed at $639000.0 in Q1 2026.
• A 5-year average of $2.2 million and a median of $1.7 million in 2024 frame the typical range for Inventory Average.
• The widest YoY moves for Inventory Average: up 11.18% in 2025, down 55.9% in 2025.
• Over 5 years, Inventory Average stood at $3.7 million in 2022, then tumbled by 39.17% to $2.3 million in 2023, then tumbled by 35.47% to $1.5 million in 2024, then sank by 55.9% to $649000.0 in 2025, then dropped by 1.54% to $639000.0 in 2026.
• The last three Inventory Average figures came in at $639000.0 (Q1 2026), $649000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.